Catalina Tejero, Dean of IE School of Arts & HumanitiesKorean Literature, Cultural Exchange and the Humanities in the Age of AI
De la Academia a la ConsultoríaEl Viaje Estratégico de Byung-Ik Jung como Anderson Consulting Partner
Empoderando a Innovadores Glocales a través de la Perspectiva Global y la Acción LocalLa visión del Decano Joon-Ki Han para Busan International College
Catalina Tejero, Dean of IE School of Arts & HumanitiesKorean Literature, Cultural Exchange and the Humanities in the Age of AI
Defining ‘New Luxury’ in the Intelligent Era: AITO Debuts Its Global Product Lineup at IAA MOBILITY 2025
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM
Sherwood Ford Hosts Fill a Ford Food Drive and Ford Dealer Days to Support Local Families and Celebrate Community
Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Quanex Building Products Corporation (NX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Circulation publie les résultats à 6 mois de la première étude VCAS chez l’homme concernant le système d’ablation par champ pulsé FieldForce™ : 82 % d’absence de récidive de TV/FV et 98 % de réduction de la charge
Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden
SPECIALTY STEEL INDUSTRY OF NORTH AMERICA APPLAUDS TRUMP ADMINISTRATION’S ACTIONS TO ADDRESS GLOBAL EXCESS STEEL CAPACITY
PONANT EXPLORATIONS GROUP ANNOUNCES NEW PARTNERSHIP WITH WOODS HOLE OCEANOGRAPHIC INSTITUTION (WHOI), THE WORLD’S LEADING ORGANIZATION DEDICATED TO OCEAN RESEARCH, EXPLORATION, AND EDUCATION
Circulation publica los resultados del primer ensayo VCAS en humanos del sistema de ablación FieldForce™
Circulation veröffentlicht die 6-Monats-Ergebnisse der ersten VCAS-Studie am Menschen mit dem FieldForce™ Pulsed Field Ablation System: 82 % Freiheit von VT/VF-Rezidiven und 98 % Reduzierung der Belastung
